Bids Are Invited For Acquisition Of Chemotherapy Medicines 2025, Requested By The Central Manipulation Section Of The Hospital Das Forças Armadas Hfa (Ssei No. 60550.015281/202567)

Acquisition Of Chemotherapy Medicines 2025, Requested By The Central Manipulation Section Of The Hospital Das Forças Armadas Hfa (Ssei No. 60550.015281/202567). Abemaciclib,Abemaciclib,Acalabrutinib,Abiraterone Acetate,Degarelix,Degarelix,Zoledronic Acid,Adalimumab,Alectinib,Anastrozole,Apalutamide,Atezolizumab,Azacytidine,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Bortezomib,Brentuximab Vedotin,Capecitabine,Carboplatin,Cemiplimab,Cetuximab,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cisplatin,Dacarbazine,Dacarbazine,Daratumumab,Darolutamide,Denosumab,Denosumab,Docetaxel,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride, Durvalumab, Enzalutamide, Etoposide, Everolimus, Exemestane, Filgrastim, Filgrastim, Fluorouracil, Fosaprepitant Dimeglumine, Fulvestrant, Ganciclovir Sodium, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride, Golimumab, Goserelin Acetate, Goserelin Acetate, Hydroxyurea, Ifosfamide, Imatinib Mesylate, Infliximab, Ipilimumab, Irinotecan Hydrochloride, Lenalidomide, Lenalidomide, Lenalidomide, Lenalidomide, Letrozole, Mesna, Mesna, Methotrexate, Methotrexate, Natalizumab, Nilotinib, Nivolumab, Nivolumab,Obinutuzumab,Octreotide,Olaparib,Olaparib,Osimertinib,Oxaliplatin,Oxaliplatin,Paclitaxel,Paclitaxel,Palbociclib,Palonosetron Hydrochloride, Palonosetron Hydrochloride, Panitumumab, Pazopanib, Pazopanib, Pembrolizumab, Pemetrexed, Pertuzumab, Ramucirumab, Ramucirumab, Ribociclib, Rituximab, Rituximab, Sacituzumab Govitecana, Secukinumab, Tamoxifen Citrate, Temozolomide, Temozolomide, Temozolomide